Press releases

18
Jun 2014
20:30 E.S.T.

Pfizer and Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration

Read more
9
Jun 2014
20:30 E.S.T.

Cellectis enters into an agreement with CELLforCURE for the cGMP manufacturing of allogeneic CART cells

Read more
5
Jun 2014
20:30 E.S.T.

Cellectis and Thermo Fisher Scientific Enter Into Agreements on TALEN™, a Leading Gene Editing Technology

Read more
5
Jun 2014
20:30 E.S.T.

Cellectis and Accelera (Nerviano Medical Sciences Group) sign an agreement to complete preclinical studies of Cellectis’ lead product candidate UCART19

Read more
29
May 2014
20:30 E.S.T.

Cellectis plant sciences reports improvement of oil content in algae

Read more
23
May 2014
20:30 E.S.T.

Cellectis plant sciences reports generation of High Oleic Soybean in Journal of Plant Biotechnology

Read more
19
May 2014
20:30 E.S.T.

TAL-effector nuclease: The USPTO issues a fourth patent licensed to Cellectis

Read more
11
Apr 2014
20:30 E.S.T.

Cellectis: 2013 financial results

Read more
31
Mar 2014
20:30 E.S.T.

Cellectis announces the closing of €20.5 M share capital increase subscribed on March 24, 2014 by U.S. Biotechnology Specialist Institutional Investors

Read more
31
Mar 2014
20:30 E.S.T.

Cellectis Receives €20.5 M in Commitments in Private Placement from U.S. Biotechnology Specialist Institutional Investors

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US